Inhibition of Exosome Release by Ketotifen Enhances Sensitivity of Cancer Cells to Doxorubicin

Cancer Biology and Therapy - United States
doi 10.1080/15384047.2017.1394544
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin

2016English

YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine

Nutrients
NutritionFood ScienceDietetics
2016English

Sensitivity of Doxorubicin-Resistant Cells to Sorafenib: Possible Role for Inhibition of Eukaryotic Initiation Factor-2α Phosphorylation

International Journal of Oncology
Cancer ResearchOncology
2010English

PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2005English

Rapamycin Enhances the Sensitivity of ER‑positive Breast Cancer Cells to Tamoxifen by Upregulating P73 Expression

Oncology Reports
MedicineCancer ResearchOncology
2018English

Correction: A Ca2+-Stimulated Exosome Release Pathway in Cancer Cells Is Regulated by Munc13-4

Journal of Cell Biology
MedicineCell Biology
2019English

Adiponectin/T-Cadherin System Enhances Exosome Biogenesis and Decreases Cellular Ceramides by Exosomal Release

JCI insight
Medicine
2018English

Inhibition of USP2 Eliminates Cancer Stem Cells and Enhances TNBC Responsiveness to Chemotherapy

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Nutlin-3 Enhances the Bortezomib Sensitivity of P53-Defective Cancer Cells by Inducing Paraptosis

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy